Board of Directors PDF Print E-mail

Belief in a Mission...The PhRMA Foundation is lastingly indebted to a cadre of PhRMA Board members who despite uncommon demands on their time through the nature of their jobs have given more than three decades of faithful and sagacious service.

They have done so, plainly, because they believed in what the Foundation was doing, and they believed in its potential for even greater performance in an essential mission.

Garry A. Neil, M.D.
Garry A. Neil, M.D.
Chairman
Corporate Vice President, Corporate
Office of Science & Technology
Johnson & Johnson
Raritan, New Jersey


Ivan Gergel, M.D.
Executive Vice President, R&D
Endo Pharmaceuticals
Chadds Ford, Pennsylvania


Howard G. Hutchinson, M.D.
Chief Medical Officer
AstraZeneca Pharmaceuticals Inc.
Wilmington, Delaware

 


Peter S. Kim, Ph.D.
President
Merck Research Laboratories
Merck & Co.
North Wales, Pennsylvania
John M. Leonard, M.D.
John M. Leonard, M.D.
Vice President of Global Scientific and Medical Affairs
Abbott Laboratories
Abbott Park, Illinois


Jan M. Lundberg,Ph.D.
Executive Vice President, Science and Technology
President, Lilly Research Laboratories
Eli Lilly and Company
Indianapolis, Indiana

Moncef Slaoui, Ph.D.
Moncef Slaoui, Ph.D.
Chairman, Research & Development
GlaxoSmithKline
King of Prussia, Pennsylvania


Billy Tauzin
President and Chief Executive Officer
PhRMA
Washington, DC
 

BENEFACTORS


The PHRMA Foundation owes its success to the pharmaceutical companies that have provided their generous support over the past 43 years.Use the arrows to scroll benefactors and click their logo to learn more about them.

View all benefactors.

 

Left direction
Right direction
logo

(C) 2010 PhRMA Foundation - 950 F Street, N.W. Suite 300 Washington, DC 20004